HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (19) Citing Articles via Google Scholar Google Scholar Articles by Eagan, T.M.L. Articles by Bakke, P.S. Search for Related Content PubMed PubMed Citation Articles by Eagan, T.M.L. Articles by Bakke, P.S.

Remission of respiratory symptoms by smoking and occupational exposure in a cohort study

¹ Dept of Thoracic Medicine, Haukeland University Hospital, ² Institute of Medicine, University of Bergen, ³ Centre for Clinical Research, Haukeland University Hospital, and ⁴ Section for Medical Statistics, University of Bergen, Bergen, Norway

CORRESPONDENCE: T. Eagan, Dept of Thoracic Medicine, Haukeland University Hospital, N-5021, Bergen, Norway. Fax: 47 55975149. E-mail: Tomas.Eagan@med.uib.no

Keywords: Cohort study, occupational exposure, remission, respiratory symptoms, smoking

Received: April 11, 2003
Accepted November 11, 2003

Few studies have estimated the remission rates of respiratory symptoms in general populations. No community cohort studies have examined the impact of smoking cessation and previous dust or fumes exposure on the remission of respiratory symptoms.

In the Hordaland County Study, an 11-yr community cohort (1985–1996/1997) from Western Norway, data from 2,819 subjects were used to examine the remission of six respiratory symptoms.

The measured cumulative remission varied from 42.3% for morning cough to 58.4% for chronic cough. Smoking cessation was a significant predictor of remission of the cough symptoms and wheezing, with odds ratios (OR) (95% confidence intervals (CI)) varying from 2.2 (1.3–3.7) for wheezing to 6.2 (3.5–11.2) for morning cough, after adjustment for sex, age, pack-years smoked, previous dust or fumes exposure, and educational level. In those not previously exposed to dust or fumes, the adjusted OR (95% CI) for the remission of morning cough, phlegm cough, dyspnoea grade 2, attacks of dyspnoea and wheezing varied from 1.5 (0.9–2.5) for attacks of dyspnoea to 2.1 (1.1–3.9) for dyspnoea grade 2, as compared to those previously exposed to dust or fumes.

This study suggests a beneficial effect of smoking cessation and an adverse effect of occupational exposure on the remission of respiratory symptoms.

This article has been cited by other articles:

				T. B. Grydeland, A. Dirksen, H. O. Coxson, S. G. Pillai, S. Sharma, G. E. Eide, A. Gulsvik, and P. S. Bakke Quantitative computed tomography: emphysema and airway wall thickness by sex, age and smoking Eur. Respir. J., October 1, 2009; 34(4): 858 - 865. [Abstract] [Full Text] [PDF]

				C. Schindler, D. Keidel, M. W. Gerbase, E. Zemp, R. Bettschart, O. Brandli, M. H. Brutsche, L. Burdet, W. Karrer, B. Knopfli, et al. Improvements in PM10 Exposure and Reduced Rates of Respiratory Symptoms in a Cohort of Swiss Adults (SAPALDIA) Am. J. Respir. Crit. Care Med., April 1, 2009; 179(7): 579 - 587. [Abstract] [Full Text] [PDF]

				G. Viegi, F. Pistelli, D. L. Sherrill, S. Maio, S. Baldacci, and L. Carrozzi Definition, epidemiology and natural history of COPD Eur. Respir. J., November 1, 2007; 30(5): 993 - 1013. [Abstract] [Full Text] [PDF]

				C. H. van Gool, G. I. J. M. Kempen, B. W. J. H. Penninx, D. J. H. Deeg, and J. Th. M. van Eijk Chronic Disease and Lifestyle Transitions: Results From the Longitudinal Aging Study Amsterdam J Aging Health, June 1, 2007; 19(3): 416 - 438. [Abstract] [PDF]

				P. Tonnesen, L. Carrozzi, K. O. Fagerstrom, C. Gratziou, C. Jimenez-Ruiz, S. Nardini, G. Viegi, C. Lazzaro, I. A. Campell, E. Dagli, et al. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy Eur. Respir. J., February 1, 2007; 29(2): 390 - 417. [Abstract] [Full Text] [PDF]

				A Frostad, V Soyseth, T Haldorsen, A Andersen, and A Gulsvik Respiratory symptoms and 30 year mortality from obstructive lung disease and pneumonia Thorax, November 1, 2006; 61(11): 951 - 956. [Abstract] [Full Text] [PDF]

				A. Lindberg, B. Eriksson, L.-G. Larsson, E. Ronmark, T. Sandstrom, and B. Lundback Seven-Year Cumulative Incidence of COPD in an Age-Stratified General Population Sample. Chest, April 1, 2006; 129(4): 879 - 885. [Abstract] [Full Text] [PDF]